Pamela Fralick

Proposed PMPRB regulations requires focused dialogue with all players

• In December the federal government formally announced it was delaying the implementation of the Patented Medicine Prices Review Board (PMPRB)’s regulatory changes. There were

Opinion | BY PAMELA FRALICK | February 17, 2022

Proposed PMPRB regulations requires focused dialogue with all players

Opinion | BY PAMELA FRALICK | February 17, 2022

• In December the federal government formally announced it was delaying the implementation of the Patented Medicine Prices Review Board (PMPRB)’s regulatory changes. There were

Proposed PMPRB regulations requires focused dialogue with all players

Opinion | BY PAMELA FRALICK | February 17, 2022

• In December the federal government formally announced it was delaying the implementation of the Patented Medicine Prices Review Board (PMPRB)’s regulatory changes. There were

Equal, affordable access to medicines in Canada is possible

• Across the country, there’s a growing challenge facing federal and provincial governments alike: “this is a breakthrough treatment, but how will we pay for

Opinion | BY PAMELA FRALICK | May 10, 2017

Equal, affordable access to medicines in Canada is possible

Opinion | BY PAMELA FRALICK | May 10, 2017

• Across the country, there’s a growing challenge facing federal and provincial governments alike: “this is a breakthrough treatment, but how will we pay for

Equal, affordable access to medicines in Canada is possible

Opinion | BY PAMELA FRALICK | May 10, 2017

• Across the country, there’s a growing challenge facing federal and provincial governments alike: “this is a breakthrough treatment, but how will we pay for

More Stories